Anzeige
Mehr »
Login
Dienstag, 29.11.2022 Börsentäglich über 12.000 News von 681 internationalen Medien
Breaking News! Rallye und Ausbruch die logische Konsequenz?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoEverest Medicines announces regulatory updates in Taiwan, South Korea for Nefecon
FrJunshi Biosciences seeks UK's marketing authorisation for toripalimab
DoFDA grants priority review to Takeda's BLA for dengue vaccine candidate
MiInnoCare receives approval in Singapore for mantle cell lymphoma therapy
22.11.Graybug, CalciMedica sign agreement to create new biopharmaceutical company
21.11.KemPharm receives Orphan Drug Designation for idiopathic hypersomnia prodrug
18.11.Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology
17.11.Curevo Vaccine announces closing of $26m Series A1 round
16.11.CG Oncology raises $120m through Series E round
15.11.NICE recommends MSD's pembrolizumab to treat breast cancer
14.11.US FDA accepts Amneal's NDA for IPX203 to treat Parkinson's disease
11.11.Harbour BioMed, Moderna partner on immunotherapies development
10.11.UK's MHRA approves Beyfortus (nirsevimab) to prevent RSV in infants
09.11.Immunomic Therapeutics receives FTD for ITI-3000 programme to treat Merkel Cell Carcinoma
08.11.Navrogen signs agreement with US NCI for NAV-001 development
07.11.Amgen's olpasiran reduces cardiovascular disease risk factor in Phase II study
04.11.ReiThera receives AIFA approval to open new production facility in Italy
03.11.BeiGene receives EC marketing approval for MZL therapy
02.11.PharmaTher, CWRU enter into agreement for Rett Syndrome therapy development
01.11.EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development
31.10.EMA accepts Almirall's MAA filing for atopic dermatitis therapy
28.10.Ariceum, AmbioPharm partner to produce and supply peptide conjugates
27.10.CSL and Translational Sciences sign license deal for thrombus dissolving drug
26.10.Normunity raises funds to develop immuno-oncology therapies
25.10.FDA grants priority review for Daiichi Sankyo's AML medicine